Cassava Sciences Stock Options Expiring on 21st of February

SAVA Stock  USD 2.73  0.00  0.00%   
Cassava Sciences' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 2.04 with a put-to-call open interest ratio of 0.6 over 50 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on February 21st 2025. The total put volume is at 168, with calls trading at the volume of 622. This yields a 0.27 put-to-call volume ratio.

Open Interest Against February 21st 2025 Option Contracts

The chart above shows Cassava Sciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cassava Sciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cassava Sciences' option, there is no secondary market available for investors to trade.

Cassava Sciences Maximum Pain Price Across 2025-02-21 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Cassava Sciences close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Cassava Sciences' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Cassava Sciences' stock options are financial instruments that give investors the right to buy or sell shares of Cassava Sciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cassava stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cassava Sciences' stock price goes up or down, the stock options follow.
At present, Cassava Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 625.7 M, whereas Total Stockholder Equity is forecasted to decline to about 80.1 M.

Cassava Sciences In The Money Call Balance

When Cassava Sciences' strike price is surpassing the current stock price, the option contract against Cassava Sciences stock is said to be in the money. When it comes to buying Cassava Sciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Cassava Sciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Cassava Current Options Market Mood

Cassava Sciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cassava Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Cassava Sciences' options investors are not very successful. Cassava Sciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Cassava contract

Base on the Rule 16, the options market is currently suggesting that Cassava Sciences will have an average daily up or down price movement of about 0.13% per day over the life of the 2025-02-21 option contract. With Cassava Sciences trading at USD 2.73, that is roughly USD 0.003481. If you think that the market is fully incorporating Cassava Sciences' daily price movement you should consider buying Cassava Sciences options at the current volatility level of 2.04%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Cassava Sciences Option Chain

When Cassava Sciences' strike price is surpassing the current stock price, the option contract against Cassava Sciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Cassava Sciences' option chain is a display of a range of information that helps investors for ways to trade options on Cassava. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Cassava. It also shows strike prices and maturity days for a Cassava Sciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
SAVA250221C00001500101.51.13 - 1.291.2In
Call
SAVA250221C0000100061.01.6 - 2.01.65In
Call
SAVA250221C000035002983.50.08 - 0.130.11Out
Call
SAVA250221C00003000208373.00.17 - 0.190.18Out
Call
SAVA250221C0000250012992.50.3 - 0.410.37In
Call
SAVA250221C000020002542.00.71 - 0.810.75In
Call
SAVA250221C00005500425.50.0 - 0.080.03Out
Call
SAVA250221C0000500032335.00.03 - 0.040.03Out
Call
SAVA250221C000045002164.50.0 - 0.110.05Out
Call
SAVA250221C0000400015254.00.06 - 0.070.06Out
Call
SAVA250221C0000750012747.50.01 - 0.050.01Out
Call
SAVA250221C00010000301510.00.01 - 0.050.02Out
Call
SAVA250221C000125004412.50.0 - 0.320.1Out
Call
SAVA250221C0001500020315.00.0 - 0.10.02Out
Call
SAVA250221C000175005217.50.0 - 0.270.01Out
Call
SAVA250221C0002000033120.00.0 - 0.030.01Out
Call
SAVA250221C0002250013722.50.0 - 0.20.09Out
Call
SAVA250221C0002500010125.00.0 - 0.310.07Out
Call
SAVA250221C0003000018630.00.0 - 0.020.01Out
Call
SAVA250221C0003500031735.00.0 - 0.020.01Out
Call
SAVA250221C0004000016040.00.0 - 0.250.82Out
Call
SAVA250221C000450004245.00.0 - 0.240.1Out
Call
SAVA250221C000500009850.00.0 - 0.020.05Out
Call
SAVA250221C000550005855.00.0 - 0.10.01Out
Call
SAVA250221C00060000184260.00.0 - 0.010.02Out
 Put
SAVA250221P00001500211.50.0 - 0.330.05Out
 Put
SAVA250221P00001000101.00.0 - 0.320.08Out
 Put
SAVA250221P00003500113.50.84 - 0.960.87In
 Put
SAVA250221P000030001673.00.45 - 0.540.62In
 Put
SAVA250221P0000250016642.50.17 - 0.210.17Out
 Put
SAVA250221P0000200011602.00.04 - 0.080.06Out
 Put
SAVA250221P0000550045.52.74 - 2.882.85In
 Put
SAVA250221P00005000111215.02.25 - 2.392.36In
 Put
SAVA250221P00004500114.51.71 - 1.891.88In
 Put
SAVA250221P00004000364.01.14 - 1.541.41In
 Put
SAVA250221P000075002107.54.75 - 4.854.88In
 Put
SAVA250221P00010000460410.07.2 - 7.357.28In
 Put
SAVA250221P0001250015012.59.7 - 9.859.78In
 Put
SAVA250221P00015000124115.012.2 - 12.312.3In
 Put
SAVA250221P0001750012717.514.7 - 14.814.4In
 Put
SAVA250221P0002000051420.017.0 - 17.616.9In
 Put
SAVA250221P0002250010722.519.7 - 19.819.55In
 Put
SAVA250221P000250002725.022.2 - 22.322.32In
 Put
SAVA250221P00030000730.027.1 - 27.5527.02In
 Put
SAVA250221P00035000135.031.85 - 32.4532.0In
 Put
SAVA250221P00040000140.037.1 - 37.436.28In
 Put
SAVA250221P000450001345.041.85 - 42.3531.6In
 Put
SAVA250221P00050000750.047.05 - 47.436.0In
 Put
SAVA250221P00055000055.052.15 - 52.3552.15In
 Put
SAVA250221P000600001960.056.95 - 57.5545.11In

Cassava Sciences Market Cap Over Time

   Market Cap   
       Timeline  

Cassava Total Stockholder Equity

Total Stockholder Equity

80.11 Million

At present, Cassava Sciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Cassava Sciences Corporate Management

Christopher JDCompany VPProfile
James MDChief OfficerProfile
Michael ZamlootSenior OperationsProfile
Jaren LandenChief OfficerProfile
Michael PharmDSenior AffairsProfile
Lindsay BurnsSenior NeuroscienceProfile
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.38)
Return On Assets
(0.46)
Return On Equity
(0.11)
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.